Sleep Disorders in Wilson's Disease.
Study Design
- अध्ययन प्रकार
- Review
- जनसंख्या
- None
- हस्तक्षेप
- Sleep Disorders in Wilson's Disease. None
- तुलनित्र
- None
- प्राथमिक परिणाम
- None
- प्रभाव की दिशा
- Positive
- पूर्वाग्रह का जोखिम
- Unclear
Abstract
PURPOSE OF REVIEW: We aimed to review the sleep disorders described in Wilson's disease (WD), focusing on their mechanisms and treatments. RECENT FINDINGS: REM sleep behavior disorder or sleepiness can be warning signs of future WD. These early symptoms may significantly reduce the time to WD diagnosis. Early anti-copper therapies (chelators or zinc salts), reducing copper accumulation in the brain and though saving brain tissue, can allow the complete disappearance of these sleep disorders and of course improve the other symptoms of WD. Insomnia, restless legs syndrome (RLS), daytime sleepiness, cataplexy, and REM sleep behavior disorder (RBD) are present in WD and should be explored with video polysomnography and multiple sleep latency test. Suggested immobilization test could be useful in the diagnosis of RLS in WD. Motor and non-motor symptoms, dysautonomic dysfunctions, drugs, and lesions of the circuits regulating wake and sleep may be involved in the mechanisms of these sleep abnormalities. Adapted treatments should be proposed.
संक्षेप में
The sleep disorders described in Wilson’s disease (WD) are reviewed, focusing on their mechanisms and treatments, and suggested immobilization test could be useful in the diagnosis of RLS in WD.
Used In Evidence Reviews
Similar Papers
The Journal of nutrition · 2003
Zinc deficiency, infectious disease and mortality in the developing world.
The British journal of nutrition · 2002
The immune system: a target for functional foods?
Journal of the American Society of Nephrology : JASN · 1999
Intake of vitamins B6 and C and the risk of kidney stones in women.
Public health nutrition · 2008
Iron and zinc deficiencies in China: what is a feasible and cost-effective strategy?
CNS drugs · 2022
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Journal of the American Geriatrics Society · 2011